Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2011 | Letter to the Editor

Suggested randomized, controlled trial for frovatriptan: a reply

Authors: Stefano Omboni, Lorenzo Pinessi, Lidia Savi, Brigida Fierro, Marco Bartolini, Carlo Lisotto, Giorgio Zanchin

Published in: The Journal of Headache and Pain | Issue 6/2011

Excerpt

Dear Sir, …

Tfelt-Hansen P, Steiner TJ (2011) Suggested randomized, controlled trial with frovatriptan. J Headache Pain. doi:10.1007/s10194-011-0381-x

Tullo V, Allais G, Ferrari MD, Curone M, Mea E, Omboni S, Benedetto C, Zava D, Bussone G (2010) Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci 31(Suppl 1):S51–S54, 20464583, 10.1007/s10072-010-0273-xPubMedCrossRef

Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D et al (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain 12:219–226, 20686810, 10.1007/s10194-010-0243-y, 1:CAS:528:DC%2BC3MXksVCgu70%3DPubMedCentralPubMedCrossRef

Bartolini M, Giamberardino MA, Lisotto C, Marteletti P, Moscato D, Panascia B et al (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 12:361–368, 21437714, 10.1007/s10194-011-0325-5, 1:CAS:528:DC%2BC3MXmtFSmsb8%3DPubMedCentralPubMedCrossRef

Cortelli P, Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies. Neurol Sci 32(Suppl 1):S95–S98, 21533722, 10.1007/s10072-011-0551-2PubMedCrossRef

Lipton RB, Cutrer FM, Goadsby PJ, Ferrari MD, Dodick DW, McCrory D, Liberman JN, Williams P (2005) How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin 21:413–424, 15811210, 10.1185/030079905X36387, 1:CAS:528:DC%2BD2MXktl2hsro%3DPubMedCrossRef

Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME (2004) Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache 44:661–668, 15209687, 10.1111/j.1526-4610.2004.04124.xPubMedCrossRef

World Health Organization (2010) WHO model list of essential 78 medicines, 16th list. WHO, Geneva. http://www.who.int/medicines/79publications/essentialmedicines/Updated_sixteenth_adult_list_80en.pdf

Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type Headache, Cluster Headache, Medication-Overuse, Headache. 3rd edition (1st revision) (2010). http://217.174.249.183/upload/NS_BASH/2010_BASH_Guidelines.pdf

10.

Lampl C, Voelker M, Diener HC (2007) Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. J Neurol 254:705–712, 17406776, 10.1007/s00415-007-0547-2, 1:CAS:528:DC%2BD2sXovFait7w%3DPubMedCrossRef

11.

Lampl C, Voelker M, Steiner TJ (2011) Aspirin is first-line treatment for migraine and episodic tension-type headache regardless of headache intensity. Headache. [Epub ahead of print]

12.

Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259–1287, 11152011, 10.2165/00003495-200060060-00003, 1:CAS:528:DC%2BD3MXktFarsA%3D%3DPubMedCrossRef

13.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633–658, 12383060, 10.1046/j.1468-2982.2002.00404.x, 1:STN:280:DC%2BD38njtlehtw%3D%3DPubMedCrossRef

14.

Lanas A, McCarthy D, Voelker M, Brueckner A, Senn S, Baron JA (2011) Short-term acetylsalicylic Acid (aspirin) use for pain, Fever, or colds—gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Drugs R D 11:277–288, 21902288PubMedCentralPubMedCrossRef

Title: Suggested randomized, controlled trial for frovatriptan: a reply
Authors: Stefano Omboni
Lorenzo Pinessi
Lidia Savi
Brigida Fierro
Marco Bartolini
Carlo Lisotto
Giorgio Zanchin
Publication date: 01-12-2011
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 6/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-011-0396-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Suggested randomized, controlled trial for frovatriptan: a reply

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2011

A painful tic convulsif due to double neurovascular impingement

Clinical features of headache patients with fibromyalgia comorbidity

Jean Schoenen, David W. Dodick, Peter S. Sándor: Comorbidity in Migraine

Familial occipital neuralgia with sporadic NIN: a reply

Thunderclap headache triggered by micturition: responsive to nimodipine

Juvenile myoclonic epilepsy presenting as a new daily persistent-like headache